PMCB

PMCB

USD

PharmaCyte Biotech Inc. Common Stock

$0.890-0.010 (-1.111%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$0.900

High

$0.917

Low

$0.880

Volume

0.00M

Company Fundamentals

Market Cap

6.0M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.10M

Exchange

NCM

Currency

USD

52-Week Range

Low $0.8Current $0.890High $1.94

Related News

BusinessWire

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartner's 2025 Hype Cycle for Data Center Infrastructure Technologies PharmaCyte Biotech, Inc. (NASDAQ:PMCB)

View more
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
BusinessWire

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company"), today announced the closing of its previously announced $7 million financing. As of April 30, 2025, PharmaCyte had approximately $15.5 million in

View more
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
BusinessWire

PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") announced today that it has entered into a securities purchase agreement for a $7.0 million financing with existing investors involving the sale of

View more
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors